PMN
ProMIS Neurosciences Inc.
9.40$
+0.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
ProMIS Neurosciences Inc. (PMN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -28 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.3 | -5.4 | -3.3 | -4.0 | -2.3 | -2.3 | -2.0 | -1.6 | -1.4 | -1.1 | -1.9 | -4.5 | -6.3 | -6.1 | -4.4 | -9.4 | -23 | -11 | -27 | -28 | |
| 0.0 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | |
| – | – | – | 0.9 | 1.0 | 0.5 | 0.2 | 0.1 | 0.5 | 0.4 | 0.4 | 0.6 | 0.8 | 0.6 | 0.4 | 0.5 | 0.7 | 0.3 | 0.8 | 0.9 | |
| – | – | – | – | – | – | – | – | – | – | – | – | 1.1 | 0.6 | 0.4 | 1.4 | -4.6 | – | – | – | |
| 0.0 | 0.5 | -0.2 | -0.2 | -0.3 | 0.4 | -0.1 | -0.1 | -0.1 | 0.0 | 0.3 | -0.3 | 0.3 | 0.8 | 0.8 | -1.6 | 7.3 | 2.9 | -12 | 11 | |
| 0.1 | 0.2 | 0.5 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 2.6 | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| -4.6 | 5.1 | 5.1 | 0.0 | 3.6 | 0.5 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -1.6 | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | 8.7 | 8.7 | 8.7 | 8.7 | 0.0 | – | – | – | |
| 5.5 | 0.8 | 0.2 | 3.6 | 0.5 | 0.7 | 1.1 | 1.7 | 1.3 | 1.8 | 1.8 | 5.3 | 6.9 | 5.4 | 3.8 | 26 | 8.7 | 18 | 28 | 21 | |
| 1.3 | 1.3 | -1.3 | -1.3 | -0.3 | -1.2 | -1.2 | -0.8 | 0.0 | 0.6 | -0.1 | 0.8 | 0.5 | -0.7 | -0.6 | 16 | -15 | 6.7 | 0.7 | -7.2 | |
| -1.4 | -3.1 | -5.9 | -3.4 | -4.0 | -2.3 | -2.3 | -2.0 | -1.6 | -1.1 | -1.9 | -4.5 | -6.3 | -6.1 | -4.5 | -9.4 | -23 | -11 | -27 | -28 |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.